Leap Therapeutics Rebrands as Cypherpunk, Buys 203,775 ZEC with Winklevoss Backing
Leap Therapeutics, a Cambridge-based biotech, has rebranded as Cypherpunk Technologies Inc. and disclosed a purchase of 203,775 Zcash (ZEC) to hold in its corporate treasury. The company described the shift as a strategic blend of its existing biotech business and a new focus on digital-asset holdings, and stated the move is backed by an investment from the Winklevosses. The announcement signals a notable pivot from pure biotech operations to a hybrid corporate model that includes significant crypto exposure.
The decision matters because Zcash is a privacy-focused coin and adding it to a corporate treasury could draw regulatory attention even as it diversifies balance-sheet assets. The trade also underscores a broader trend of public companies adopting crypto for treasury management. Investors and regulators will likely watch subsequent filings for details on purchase price, custody arrangements, and how Cypherpunk intends to govern the combined business strategy.